Literature DB >> 14179556

MITHRAMYCIN IN THE TREATMENT OF EMBRYONAL CANCER.

S KOFMAN, T J MEDREK, R W ALEXANDER.   

Abstract

Entities:  

Keywords:  ANTIBIOTICS; ANTINEOPLASTIC AGENTS; CHORIOCARCINOMA; DISGERMINOMA; NEGROES; NEOPLASM METASTASIS; OVARIAN NEOPLASMS; PROSTATIC NEOPLASMS; SARCOMA, EWING'S; TERATOID TUMOR; TESTICULAR NEOPLASMS; TOXICOLOGIC REPORT

Mesh：

Substances：

Year:  1964        PMID： 14179556     DOI： 10.1002/1097-0142(196407)17:7<938::aid-cncr2820170714>3.0.co;2-n

Source DB:  PubMed          Journal:  Cancer        ISSN： 0008-543X            Impact factor:   6.860


× No keyword cloud information.
  8 in total

Review 1.  Drugs for disorders of bone: pharmacological and clinical considerations.

Authors:  G R Mundy; L G Raisz
Journal:  Drugs       Date:  1974       Impact factor: 9.546

2.  Identification of an inhibitor of the EWS-FLI1 oncogenic transcription factor by high-throughput screening.

Authors:  Patrick J Grohar; Girma M Woldemichael; Laurie B Griffin; Arnulfo Mendoza; Qing-Rong Chen; Choh Yeung; Duane G Currier; Sean Davis; Chand Khanna; Javed Khan; James B McMahon; Lee J Helman
Journal:  J Natl Cancer Inst       Date:  2011-06-08       Impact factor: 13.506

3.  Development of Mithramycin Analogues with Increased Selectivity toward ETS Transcription Factor Expressing Cancers.

Authors:  Prithiba Mitra; Joseph M Eckenrode; Abhisek Mandal; Amit K Jha; Shaimaa M Salem; Markos Leggas; Jürgen Rohr
Journal:  J Med Chem       Date:  2018-08-28       Impact factor: 7.446

4.  Ewing sarcoma and related FET family translocation-associated round cell tumors: A century of clinical and scientific progress.

Authors:  Robert G Maki; Patrick J Grohar; Cristina R Antonescu
Journal:  Genes Chromosomes Cancer       Date:  2022-04-30       Impact factor: 4.263

5.  Identification of Mithramycin Analogues with Improved Targeting of the EWS-FLI1 Transcription Factor.

Authors:  Christy L Osgood; Nichole Maloney; Christopher G Kidd; Susan Kitchen-Goosen; Laura Segars; Meti Gebregiorgis; Girma M Woldemichael; Min He; Savita Sankar; Stephen L Lessnick; Min Kang; Malcolm Smith; Lisa Turner; Zachary B Madaj; Mary E Winn; Luz-Elena Núñez; Javier González-Sabín; Lee J Helman; Francisco Morís; Patrick J Grohar
Journal:  Clin Cancer Res       Date:  2016-03-15       Impact factor: 12.531

6.  A trial of mithramycin in the treatment of advanced malignant disease.

Authors:  I A Sewell; H Ellis
Journal:  Br J Cancer       Date:  1966-06       Impact factor: 7.640

Review 7.  Potential approaches to the treatment of Ewing's sarcoma.

Authors:  Hongjiu Yu; Yonggui Ge; Lianying Guo; Lin Huang
Journal:  Oncotarget       Date:  2017-01-17

Review 8.  Mithramycin and Analogs for Overcoming Cisplatin Resistance in Ovarian Cancer.

Authors:  David Schweer; J Robert McCorkle; Jurgen Rohr; Oleg V Tsodikov; Frederick Ueland; Jill Kolesar
Journal:  Biomedicines       Date:  2021-01-12
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.